You can read some of the January 8th print issue of Chain Drug Review here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
WEST DES MOINES, Iowa — Randy Edeker is a visionary force who has left an undeniable mark on the retail industry. Since taking the helm of Hy-Vee as chairman and chief executive officer in 2012, Edeker has transformed the regional grocer into a nationally recognized, award-winning retail brand. Edeker, who currently serves as Hy-Vee’s executive
GOUVERNEUR, N.Y. — Kinney Drugs can trace its history back to over 120 years ago when Burt Kinney established the very first store here in 1903. Over the next 95 years, the company slowly expanded to nearly 100 retail locations throughout upstate New York and Vermont. Beginning in 1998, Kinney Drugs began to diversify across
WOONSOCKET, R.I. — CVS Health has a unique opportunity, says chief merchandising officer Musab Balbale, and it’s twofold. First, as an operator of more than 9,000 stores focused on health and wellness, it has the ability to connect with members of the community seeking vital information, products and services. The company’s acquisitions of Oak Street
Most retailers talk a lot about the customer-centric imperative; CVS Health is doing something about it. In recent years, the company has been on a journey to strengthen the connective tissue uniting the various aspects of the organization, in an effort to provide a seamless experience for patients and consumers — no matter which CVS
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The Good to Great principles of author and consultant Jim Collins — a great friend of NACDS — stand the
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America. On that day, to informally recognize the 90th anniversary of the National Association of Chain Drug Stores, America’s mass retailing community gathered together a not-so-random sampling of the individuals who created, advanced and immortalized health
BENTONVILLE, Ark. — In the realm of health and wellness, the endpoint is where Walmart begins. After first gaining a thorough understanding of patients, customers and their needs, the company has set out to construct a dynamic ecosystem that promises to transform the way in which Americans get and stay well. In light of the
Leading chain drug and distribution executives provide their outlook for the coming year on the following pages, spelling out the challenges and opportunities that lie ahead for their companies and the industry. Prem Shah Executive Vice President, Chief Pharmacy Officer and President, Pharmacy and Consumer Wellness, CVS Health The need for accessible and affordable care
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive. As the market continues to demand specialization in drug distribution and
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada. All provinces further expanded pharmacists’ scope of practice and/or increased
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people. It’s the first day of a new year, of course.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review We are, without a doubt, at a tipping point with the current state of pharmacy practice. Drug shortages, staffing shortages,
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Up until a few years ago, when meeting with lawmakers to advocate for pharmacy benefit manager reform measures, we typically
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. As the oldest national professional association for pharmacists, pharmacy technicians, student pharmacists and pharmaceutical scientists, the American Pharmacists Association touches
